Report Id: SNS/HC/1013 | May 2022 | Region: Global | 125 Pages
Report Scope & Overview:
The Blood Glucose Monitoring Device Market Size was valued at USD 11.63 billion in 2021, and expected to reach USD21.15 billion by 2028, and grow at a CAGR of 7.9% over the forecast period 2022-2028. The development of diabetes patients is driving more interest for the blood glucose monitoring . A self-monitoring device assists patients with checking blood glucose levels without anyone else. There is an assortment of parts on the lookout. Glucometers, lancets and test strips are essential assortments on the lookout. There are a lot of elements that cause diabetes in patients. Corpulence prompts type 2 diabetes. The unfortunate way of life and sedimentary way of life of individuals is expanding glucose levels.
The general glucose monitoring is innovation situated. A gadget could assist with recognizing hypo and hyperglycemic conditions. In the forcast period , the blood glucose monotoring device will have good circumstances. The home setting section of the market is seeing high benefits. Through home testing, the patients have some control over glucose levels effectively. Assuming the glucose level is high visiting medical clinics for additional therapy is simple with the gadgets. The element of any blood glucose monition system is sensors, transmitters and screens. These highlights and advantages of the gadgets will prompt gigantic market advancements.
Realizing exact glucose levels in the blood is easy.
Recognition of diabetes.
Increasing demand in the market.
Deferring the treatment for the sickness.
Awerness to the framework.
Simple access of these monitoring device will prompt.
The government drives to help preventive consideration.
clinical gadgets accessible from home.
The low repayment approaches.
Many patients don't have an idea how to use it.
The High price of the device.
Impact of COVID-19
The COVID-19 pandemic has opened new open doors for blood glucose monitoring devices and these devices acquired fame in the diabetic consideration market. Mindfulness with respect to the advantages of blood glucose monitoring devices expanded among the buyers as, during the pandemic, there had been an accentuation on the utilization of virtual centers and telemedicine for diabetic administration. The blood glucose monitoring device assisted patients and medical services suppliers with improving glycemic control and possibly increment patient self-administration, subsequently changing diabetes care altogether. Further, a flood in the interest for blood glucose monitoring devices because of the fast reaction by significant market players during the Covid-19 pandemic.
Blood glucose monitoring device market size was esteemed at 11.63 billion out of 2021 and is supposed to extend at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2028. And is supposed to estimate by 21.15 billion by 2028.
Key Market Segments:
Blood Glucose Meter
Continuous Blood Glucose Monitoring Devices
Transmitter & Receiver
Medtronic plc, Sanofi, Ascensia Diabetes Care, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, Ypsomed Holdings, Novo Nordisk, Glysens Incorporated, F. Hoffmann-La Roche Ltd.
North America gained a significant portion of itself observing the blood glucose gadgets market, inferable from high-frequency pace of diabetes in the locale. Also, the presence of vital participants in the area supplements the development of the market. In any case, Asia-Pacific is supposed to develop at the quickest rate during the figure time frame, because of the expansion in the pervasiveness pace of diabetes in the area. Furthermore, the nations in the district like India and China, have the most elevated populace base, which is undiscovered with diabetes. Moreover, the continually advancing medical services industry drives the development of the market in creating economies.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2021||US$ 11.63 Billion|
|Market Size by 2028||US$ 21.15 Billion|
|CAGR||CAGR of 7.9% From 2022 to 2028|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Product (Self-monitoring Devices, Continuous Blood Glucose Monitoring Devices)
• By End-Use (Hospitals, Home Care, Diagnostic Centers)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Medtronic plc, Sanofi, Ascensia Diabetes Care, Dexcom, Inc., Abbott Laboratories, Insulet Corporation, Ypsomed Holdings, Novo Nordisk, Glysens Incorporated, F. Hoffmann-La Roche Ltd.|
|DRIVING FACTORS||• Realizing exact glucose levels in the blood is easy.
• Recognition of diabetes.
• Increasing demand in the market.
|Restraints||• Lower analysis.
• Deferring the treatment for the sickness.
• Awerness to the framework.
Frequently Asked Questions (FAQ) :
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID 19 Impact Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global blood glucose monitoring device market Segmentation, by Product Outlook
8.1 Self-monitoring Devices:
8.1.1 Blood Glucose Meter
8.1.2 Testing Strips
8.2 Global Continuous Blood Glucose Monitoring Devices:
8.2.2 Transmitter & Receiver
8.2.3 Insulin Pumps
9. Global blood glucose monitoring device market Segmentation, by End-use Outlook
9.2 Home Care
9.3 Diagnostic Centers
10. Regional Analysis
10.2 North America
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4.2 South Korea
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.3 South Africa
10.6 Latin America
10.6.3 Rest of Latin America
11. Company Profiles
11.1 Abbott Laboratories
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Medtronic plc
11.4 Ascensia Diabetes Care
11.5 Dexcom, Inc.,
11.6 Insulet Corporation
11.7 Ypsomed Holdings
11.8 Novo Nordisk
11.9 Glysens Incorporated
11.10 F. Hoffmann-La Roche Ltd.
12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share analysis
12.3 Recent Developments